基本信息
views: 44
Career Trajectory
Bio
Thirumurthy Velpandian is a Professor ( Pharmacology) at All India Institute of Medical Sciences, New Delhi.
His Pharmacology and Clinical Pharmacy Laboratories are involved in repurposing and developing drugs for Ocular therapeutics. His group is involved rationalizing drug therapy for various eye diseases and disorders like infections glaucoma, angiogenesis, diabetic complications etc. His group is also involved in addressing the effect of environmental pollutants on human with special reference to eye.
His laboratory is supported by grants from ICMR, DST, DBT, DRDO, BMGF, BIRAC and Other pharmaceutical and Start up companies.
His hobbies are Bio-electronics, Hindu Art and Theology and Yoga
Research Interests
Papers共 291 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Indian Journal of Pediatricspp.1-8, (2024)
Palak Singh,Bodhana Dhole,Jaganmoy Choudhury, Anannya Tuli,Deepak Pandey,Thirumurthy Velpandian,Surabhi Gupta,Pradeep Kumar Chaturvedi
Journal of Cellular and Molecular Medicineno. 6 (2024)
Environmental science and pollution research internationalno. 16 (2024): 23408-23434
Priyadarshini Sathe,Velmurugan Kailasam, Vasagiri Nagarjuna, Hanuman Sharma,Thirumurthy Velpandian,Prashant Garg,Jayabalan Nirmal
EUROPEAN JOURNAL OF OPHTHALMOLOGYpp.11206721241247419-11206721241247419, (2024)
Kidney International Reportsno. 4 (2024): S195-S196
The British journal of ophthalmologypp.bjo-2023, (2024)
Journal of glaucomano. 3 (2024): 149-154
Cureusno. 5 (2024): e60835-e60835
Load More
Author Statistics
#Papers: 293
#Citation: 4431
H-Index: 33
G-Index: 53
Sociability: 7
Diversity: 4
Activity: 37
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn